CDK2 was identified as a direct target of curcumin in colon cancer cells [25], and germacrone induces G1 phase arrest, associated with a significant decrease in expression of cyclin D1 and CDK2 and elevated expression of p21 [26]. Here, CDK2 is linked to malignant colon neoplasm.